489 related articles for article (PubMed ID: 18216052)
1. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).
Vestbo J; Anderson W; Coxson HO; Crim C; Dawber F; Edwards L; Hagan G; Knobil K; Lomas DA; MacNee W; Silverman EK; Tal-Singer R;
Eur Respir J; 2008 Apr; 31(4):869-73. PubMed ID: 18216052
[TBL] [Abstract][Full Text] [Related]
2. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
[TBL] [Abstract][Full Text] [Related]
3. Lessons from ECLIPSE: a review of COPD biomarkers.
Faner R; Tal-Singer R; Riley JH; Celli B; Vestbo J; MacNee W; Bakke P; Calverley PM; Coxson H; Crim C; Edwards LD; Locantore N; Lomas DA; Miller BE; Rennard SI; Wouters EF; Yates JC; Silverman EK; Agusti A;
Thorax; 2014 Jul; 69(7):666-72. PubMed ID: 24310110
[TBL] [Abstract][Full Text] [Related]
4. Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.
Halper-Stromberg E; Yun JH; Parker MM; Singer RT; Gaggar A; Silverman EK; Leach S; Bowler RP; Castaldi PJ
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):500-509. PubMed ID: 29206476
[TBL] [Abstract][Full Text] [Related]
5. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of exhaled breath condensate pH as a biomarker for COPD.
MacNee W; Rennard SI; Hunt JF; Edwards LD; Miller BE; Locantore NW; Tal-Singer R
Respir Med; 2011 Jul; 105(7):1037-45. PubMed ID: 21377342
[TBL] [Abstract][Full Text] [Related]
7. Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease.
Moll M; Boueiz A; Ghosh AJ; Saferali A; Lee S; Xu Z; Yun JH; Hobbs BD; Hersh CP; Sin DD; Tal-Singer R; Silverman EK; Cho MH; Castaldi PJ;
Am J Respir Crit Care Med; 2022 Jan; 205(2):161-170. PubMed ID: 34739356
[No Abstract] [Full Text] [Related]
8. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.
Vestbo J; Agusti A; Wouters EF; Bakke P; Calverley PM; Celli B; Coxson H; Crim C; Edwards LD; Locantore N; Lomas DA; MacNee W; Miller B; Rennard SI; Silverman EK; Yates JC; Tal-Singer R;
Am J Respir Crit Care Med; 2014 May; 189(9):1022-30. PubMed ID: 24552242
[TBL] [Abstract][Full Text] [Related]
9. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
10. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
11. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study.
McDonald ML; Diaz AA; Ross JC; San Jose Estepar R; Zhou L; Regan EA; Eckbo E; Muralidhar N; Come CE; Cho MH; Hersh CP; Lange C; Wouters E; Casaburi RH; Coxson HO; Macnee W; Rennard SI; Lomas DA; Agusti A; Celli BR; Black-Shinn JL; Kinney GL; Lutz SM; Hokanson JE; Silverman EK; Washko GR
Ann Am Thorac Soc; 2014 Mar; 11(3):326-34. PubMed ID: 24558953
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilator response of advanced lung function parameters depending on COPD severity.
Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the Early Chronic Obstructive Pulmonary Disease (ECOPD) study in Guangdong, China: a prospective observational cohort study.
Wu F; Zhou Y; Peng J; Deng Z; Wen X; Wang Z; Zheng Y; Tian H; Yang H; Huang P; Zhao N; Sun R; Chen R; Ran P
J Thorac Dis; 2021 Dec; 13(12):6924-6935. PubMed ID: 35070376
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of collagen turnover are related to annual change in FEV
Leeming DJ; Byrjalsen I; Sand JMB; Bihlet AR; Lange P; ; Thal-Singer R; Miller BE; Karsdal MA; Vestbo J
BMC Pulm Med; 2017 Dec; 17(1):164. PubMed ID: 29202744
[TBL] [Abstract][Full Text] [Related]
15. Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model.
Briggs AH; Baker T; Risebrough NA; Chambers M; Gonzalez-McQuire S; Ismaila AS; Exuzides A; Colby C; Tabberer M; Muellerova H; Locantore N; Rutten van Mölken MPMH; Lomas DA
Med Decis Making; 2017 May; 37(4):469-480. PubMed ID: 27317436
[TBL] [Abstract][Full Text] [Related]
16. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.
Rennard SI; Locantore N; Delafont B; Tal-Singer R; Silverman EK; Vestbo J; Miller BE; Bakke P; Celli B; Calverley PM; Coxson H; Crim C; Edwards LD; Lomas DA; MacNee W; Wouters EF; Yates JC; Coca I; Agustí A;
Ann Am Thorac Soc; 2015 Mar; 12(3):303-12. PubMed ID: 25642832
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.
Wan ES; Cho MH; Boutaoui N; Klanderman BJ; Sylvia JS; Ziniti JP; Won S; Lange C; Pillai SG; Anderson WH; Kong X; Lomas DA; Bakke PS; Gulsvik A; Regan EA; Murphy JR; Make BJ; Crapo JD; Wouters EF; Celli BR; Silverman EK; DeMeo DL; ; ; ;
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):304-10. PubMed ID: 21037115
[TBL] [Abstract][Full Text] [Related]
18. Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers.
Papaioannou AI; Loukides S; Minas M; Kontogianni K; Bakakos P; Gourgoulianis KI; Alchanatis M; Papiris S; Kostikas K
Respir Res; 2011 May; 12(1):67. PubMed ID: 21600044
[TBL] [Abstract][Full Text] [Related]
19. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
Donohue JF; Herje N; Crater G; Rickard K
Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
[TBL] [Abstract][Full Text] [Related]
20. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.
Martin M; Almeras N; Després JP; Coxson HO; Washko GR; Vivodtzev I; Wouters EF; Rutten E; Williams MC; Murchison JT; MacNee W; Sin DD; Maltais F
Int J Chron Obstruct Pulmon Dis; 2017; 12():451-460. PubMed ID: 28203068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
